Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
Perspectives in Nutrition, 8th Edition Chapter 12 Outline: The Fat-Soluble Vitamins After studying this chapter, you will be able to: 1. 2. 3. 4. 5. Define the term vitamin and list 3 characteristics of vitamins as a group. Classify the vitamins according to whether they are fat-soluble or water soluble. List 3 important food sources for each fat-soluble vitamin. List the major functions for each fat-soluble vitamin. Describe the deficiency symptoms for each fat-soluble vitamin and state the conditions in which deficiencies are likely to occur. 6. Describe the toxicity symptoms caused by excess consumption of certain fat-soluble vitamins. 7. Evaluate the use of vitamin and mineral supplements with respect to their potential benefits and risks to health. 12.1 Vitamins: Essential Dietary Components A. General 1. Vitamins: essential, organic substances needed in small amounts in the diet a. Fat-soluble vitamins: dissolve in organic solvents (e.g., ether, benzene) b. Water-soluble vitamins: dissolve in water 2. Supply no energy 3. Aid in growth, development, and maintenance of body tissues 4. Essential in diet because they cannot be synthesized at all or in sufficient amounts by the body to support needs 5. Health declines when vitamins are deficient 6. Resupplying vitamins alleviates deficiency symptoms 7. Megadoses of some vitamins are useful as pharmacological agents 8. Synthetic and natural forms of vitamins generally work equally well in the body 9. Vitamins consumed in foods as part of a varied diet are more beneficial than supplements B. Absorption of Vitamins 1. Fat-soluble vitamins are absorbed with dietary fat a. Requirements for absorption i. Dietary fat ii. Bile iii. Pancreatic lipase iv. Absorptive capacity of intestinal cells b. Absorption efficiency of fat-soluble vitamins is 40 - 90% when consumed in recommended amounts 2. Water-soluble vitamins are absorbed in the small intestine independent of dietary fat with 90 - 100% efficiency C. D. E. F. 12.2 Malabsorption of Vitamins 1. Fat malabsorption (e.g., from GI tract disease or pancreatic disease) may cause poor absorption of fat-soluble vitamins 2. Alcohol abuse and some intestinal diseases may cause malabsorption of some Bvitamins 3. Poor absorption increases vitamin requirements Transport of Vitamins 1. Fat-soluble vitamins are transported through lymphatic system and delivered to bloodstream via chylomicrons and other blood lipoproteins a. Triglycerides are removed by cells as chylomicrons circulate b. Remnants, which include fat-soluble vitamins, are taken up by the liver and repackaged as new lipoproteins for transport or stored in adipose tissue or liver 2. Water-soluble vitamins are delivered directly to the bloodstream and distributed throughout the body Storage of Vitamins in the Body 1. Except for vitamin K, fat-soluble vitamins are not readily excreted, but are stored in the liver and/or adipose tissue 2. Except for vitamins B-6 and B-12, water-soluble vitamins are excreted readily and poorly stored 3. Vitamins should be consumed daily, but deficiency symptoms do not develop for several weeks with inadequate consumption Vitamin Toxicity 1. Toxicity from vitamins A and D is most likely 2. Toxicity usually results when intake exceeds 5 - 10 times DRI guidelines 3. Balanced multivitamin and mineral supplements that supply less than 2X the Daily Value are unlikely to cause toxicity Vitamin A A. General 1. Vitamin A (from consumption of beef liver) has been known to prevent night blindness for >3500 years 2. Vitamin A is a family of compounds a. Preformed retinoids: biologically active form of vitamin A; three forms may be interconverted to some extent i. Retinol ii. Retinal iii. Retinoic acid b. Provitamin A carotenoids: must be converted to vitamin A 3. Carotenoids: yellow/orange pigments in fruits and vegetables; some are provitamins (converted to vitamin A) a. Alpha-carotene b. Beta-carotene B. C. D. c. Beta-cryptoxanthin Vitamin A in Foods (see Figure 12-3) 1. Sources of retinoids a. Liver b. Fish and fish oils c. Fortified milk d. Eggs e. Margarine 2. Sources of carotenoids a. Yellow/orange fruits and vegetables (e.g., carrots, spinach, winter squash, sweet potatoes, mangoes, cantaloupe, peaches, apricots) b. Leafy green vegetables c. Broccoli 3. 70% of vitamin A in typical American diet comes from animal (preformed vitamin A) sources 4. Dietary vitamin A activity is expressed in Retinol Activity Equivalents (RAE) a. 1 RAE = 1 µg retinol b. 1 RAE = 12 µg beta-carotene c. 1 RAE = 24 µg alpha-carotene or beta-cryptoxanthin 5. Outdated units of measurement for vitamin A a. International units (IU) b. Retinol equivalents (RE): overestimate contribution of carotenoids to vitamin A needs i. For preformed vitamin A, 1 RE (3.3 IU) =1 RAE ii. For provitamin A, assume 1 RE/2 = 1 RAE Vitamin A Needs 1. RDA a. Adult men: 900 µg b. Adult women: 700 µg 2. DV: 5000 IU (1000 µg) 3. No DRI available for carotenoids 4. Average intake meets DRI Absorption 1. Preformed vitamin A in animal foods a. Retinol b. Retinyl esters (attached to fatty acid); must be cleaved by action of bile and pancreatic lipase to have vitamin A activity 2. Absorption of preformed vitamin A a. Takes place in the small intestine b. Up to 90% efficient 3. Absorption of carotenoids a. Takes place in small intestine b. Absorption efficiency is lower than that of preformed vitamin A E. F. G. H. Transport of Vitamin A 1. Transport of retinoids a. After absorption, retinol is attached to a fatty acid to form a new retinyl ester and packaged into chylomicrons b. Chylomicrons are absorbed into lymphatic vessels, which empty into the bloodstream 2. Transport of carotenoids a. Enzymatically split in intestinal cells or liver cells to form retinal and retinoic acid b. Retinal is converted to retinol and can become a retinyl ester to enter lymphatic circulation c. Carotenoids can also enter bloodstream directly 3. Retinoids are released from liver into bloodstream bound to retinol-binding protein, which binds to transthyretin (prealbumin) 4. Carotenoids are released from liver into bloodstream as part of VLDL 5. Retinoids bind to specific RBPs in cells Storage of Vitamin A 1. 90% of body’s vitamin A stores are in the liver (enough to last for several months) 2. Small amounts of vitamin A are stored in adipose tissue, kidneys, bone marrow, testicles, and eyes Excretion of Vitamin A 1. Minor amount lost in urine 2. Kidney disease can lead to vitamin A toxicity because of impaired excretion Functions of Vitamin A (Retinoids) 1. Growth and Development a. Development of eyes, limbs, cardiovascular system, and nervous system of embryo b. Lack of vitamin A in first trimester leads to birth defects or fetal death c. Retinoid acid is needed for production, structure, and normal function of epithelial (mucous forming) cells in lungs, trachea, skin, GI tract, etc 2. Cell Differentiation (see Figure 12-4) a. Retinoids bind to retinoid receptors in cell nucleus that regulate formation of mRNA and subsequent gene expression, which directs cell differentiation (process by which stem cells develop into specialized cells) i. Retinoic acid receptor (RAR) ii. Retinoid X receptor (RXR) b. Especially involved in cell differentiation in the eyes 3. Vision a. Retinal is needed in the retina to turn visual light into nerve signals to the brain b. Rods: vision in dim light, black and white images, detection of motion i. ii. I. 11-cis-retinal binds to opsin to form rhodopsin Absorption of light catalyzes bleaching process: change in shape of 11-cis-retinal to all-trans-retinal, separates from opsin iii. Ion permeability of photoreceptor cells iv. Initiation of signal to nerve cells that communicate with brain’s visual center v. With exposure to bright light, rhodopsin is completely activated and cannot respond to more light vi. Regeneration of 11-cis-retinal from all-trans-retinal and binding with opsin restarts visual cycle vii. Some retinal is stored and not used for each visual cycle viii. Depletion of vitamin A pools leads to night blindness, wherein the process of dark adaptation is impaired ix. Dark adaptation: [rhodopsin] in the eye increases in dark conditions to allow vision in the dark c. Cones: vision in bright light, color vision 4. Immune Function a. Increased incidence of infection is an early symptom of vitamin A deficiency b. May be due to role of vitamin A in maintenance of epithelial cells, which form a barrier against pathogens c. Vitamin A supplementation decreases severity of infections in vitamin A deficient children 5. Use of Vitamin A Analogs in Dermatology a. Retin-A (topical) and Accutane (oral) b. Used to treat acne and psoriasis or lessen damage from sun or UV exposure c. Toxic effects are especially harmful to fetus; causes birth defects Carotenoid Functions 1. Some can be converted to vitamin A 2. Reduced risk of eye disease 3. Reduced risk of cancer 4. Reduced risk of cardiovascular disease 5. Beta-carotene may act as antioxidant, especially to protect eye tissues; diets high in fruits and vegetables show more success than supplementation 6. Possible role for beta-carotene in prevention of lung cancer: although diets high in fruits and vegetables are associated with reduced risk of lung cancer, supplementation actually increases risk of lung cancer in high-risk individuals 7. Lutein and zeaxanthin may protect against age-related macular degeneration (leads to deterioration of central vision) 8. Lycopene may protect against prostate cancer 9. J. K. Beta-carotene and lycopene may reduce risk of CVD, possibly by inhibiting oxidation of LDL and cholesterol synthesis and increasing LDL receptor activity in cells 10. In all cases, diets high in carotenoid-rich fruits and vegetables are recommended rather than carotenoid supplements Vitamin A Deficiency Diseases 1. Low risk for deficiency in North America, but vitamin A deficiency is a major public health problem in developing countries 2. Leading cause of non-accidental blindness worldwide 3. At-risk populations in North America a. Poverty b. Older adults c. Alcoholism or liver disease (limits vitamin A storage) d. Severe fat malabsorption e. Premature infants (low stores of vitamin A) 4. Effects on eyes a. Slowed regeneration of rhodophsin by rods in the retina leads to night blindness b. Deterioration of mucous-forming cells leads to xerophthalmia: progression of eye disease leading to blindness, including i. Conjunctival xerosis: dryness ii. Bitot’s spots: hardened epithelial cells on the eye iii. Keratomalacia: softening of the cornea iv. Scarring c. Follicular hyperkeratosis: keratinized cells replace normal epithelial cells, leading to dry, roughened skin d. Impaired growth in children Vitamin A Toxicity (hypervitaminosis A) 1. Occurs with chronic intake (usually from supplements) of 5 - 10 times RDA for retinoids 2. UL: 3000 µg of retinoids (no UL for carotenoids) 3. Types of hypervitaminonis A a. Acute:1 very large dose or several large doses over a few days (100 x RDA) i. GI tract upset ii. Headache iii. Blurred vision iv. Poor muscle coordination v. Fatality for extremely large doses (e.g., 500 mg for children or 10 g for adults) b. Chronic: repeated intakes of at least 10 x RDA; most symptoms disappear after supplementation ceases, but permanent damage may occur to the liver, bones, and eyes 4. 12.3 i. Joint pain ii. Loss of appetite iii. Skin disorders iv. Headache v. Reduced bone minerals vi. Liver damage vii. Double vision viii. Hemorrhage ix. Coma c. Teratogenic: toxic doses during pregnancy, usually from vitamin A analogs used to treat skin conditions, but also possible from food sources (e.g., liver, fortified breakfast cereals); pregnant women should limit intake of vitamin A to 100% DV i. Birth defects, especially of head and neck, where neural crest cells form in first trimester ii. Spontaneous abortion Consuming excessive carotenoids does not lead to toxicity; may turn skin to yellow/orange color (hypercarotenemia) Vitamin D A. General 1. In 1918, cod liver oil (source of vitamin D) was discovered as cure for rickets 2. In the presence of sunlight, skin cells can synthesize sufficient vitamin D, which makes vitamin D a “conditional vitamin” or prohormone (precursor to active hormone) a. Skin produces vitamin D3 (cholecalciferol) from a derivative of cholesterol b. Liver and kidneys add hydroxyl group to cholecalciferol to yield active vitamin D (1,25 dihydroxy D3, or calcitriol) B. Vitamin D2 (Ergocalciferol) in Foods 1. High sources a. Fatty fish (e.g., sardines, mackerel, salmon) and fish oils (e.g., cod liver oil) b. Fortified milk [10 µg (400 IU)/quart] c. Fortified breakfast cereals d. Supplements 2. Low sources a. Eggs b. Butter c. Liver d. Some brands of margarine 3. Ergocalciferol (D3) has vitamin D activity in humans, but not as much as cholecalciferol (D2) C. D. E. F. G. Vitamin D3 Formation in the Skin 1. Occurs in the liver and kidneys 2. This process provides 80 - 100% of vitamin D requirements for some people 3. Required sun exposure varies by a. Time of day b. Geographic location c. Season d. Age: skin production decreases by 70% by age 70 e. Skin color: melanin blocks UV light and prevents adequate D3 synthesis f. Use of sunscreen > SPF 8 4. Expose hands, face, and arms to UV light at least 2 - 3 times per week for 10 - 15 minutes (longer for dark-skinned individuals) 5. Prolonged skin exposure is unlikely to cause toxicity because excess previtamin D3 in the skin is rapidly degraded Vitamin D Needs 1. AI a. Adult men and women up to age 51: 5 µg (200 IU) b. Adults ages 51 - 70: 10 µg (400 IU) c. Adults ages 71+: 15 µg (600 IU); may need 20 - 25 µg from fortified foods and supplements to decrease bone loss and other chronic diseases 2. DV: 10 µg 3. Full-term infants are born with a supply of vitamin D, but American Academy of Pediatrics recommends 5 µg (200 IU)/d supplements until weaned to good food sources of vitamin D Absorption of Vitamin D 1. 80% of vitamin D2 is incorporated with dietary fats into micelles in the small intestine 2. Absorbed by small intestine 3. Packaged into chylomicrons for transport in lymph 4. Fat malabsorption syndromes increase risk for vitamin D deficiency Transport of Vitamin D 1. Vitamin D2 and D3 are transported through bloodstream bound to a protein to the adipose, liver, or kidney cells 2. In liver, vitamin D is hydroxylated to 25-OH vitamin D3 (inactive form), which may circulate in the blood for weeks 3. In kidney, 25-OH vitamin D3 is hydroxylated to 1,25-dihydroxy vitamin D3 4. Synthesis of 1,25(OH)2 vitamin D3 is tightly regulated by parathyroid gland and kidneys in response to blood calcium levels a. Low [Ca] increased 1,25(OH)2 synthesis b. High [Ca] decreased 1,25(OH)2 synthesis Storage of Vitamin D 1. 25-OH vitamin D3 circulates in bloodstream 2. Adipose cells H. I. J. K. Excretion of Vitamin D 1. Lost in bile during digestion 2. Small amount excreted in urine Functions of Vitamin D 1. Hormone-like functions that regulate body’s concentration of calcium and phosphorus (see Figure 12-13) a. Promotes increased intestinal absorption of calcium and phosphorus from foods to maintain blood levels of these minerals b. With PTH, enables release of calcium and phosphorus from the bone into the blood 2. Immune function 3. Cellular metabolism, likely regulation of cell cycle 4. Possible protection against cancer 5. Possible protection against diabetes 6. Possible protection against hypertension Vitamin D Deficiency Diseases 1. In children, deficiency leads to rickets: abnormal mineralization of skeleton a. Signs i. Enlarged head, joints, and ribcage ii. Deformed pelvis iii. Bowed legs b. At-risk populations i. Fat malabsorption ii. Dark skin pigmentation iii. Low milk intake iv. Minimal sun exposure 2. In adults, deficiency leads to osteomalacia: soft bones a. Signs i. Poor calcification of newly synthesized bone ii. Hip, spine, and other fractures b. At-risk populations i. Kidney disease ii. Liver disease iii. Gallbladder disease iv. Intestinal disease v. Dark skin pigmentation vi. Limited UV exposure 3. Those with low 25-OH vitamin D3 levels should take 20 - 25 µg/d of vitamin D until normalized, then maintenance dose of 10 µg/d Vitamin D Toxicity 1. Only likely from excessive supplementation 2. Vitamin D in skin is readily broken down 3. UL: 50 µg (2000 IU) 4. 12.4 Consequences a. Overabsorption of calcium b. Hypercalcemia (high blood calcium) c. Calcium deposits in kidneys, heart, and lungs d. Anorexia e. Nausea/vomiting f. Bone demineralization g. Weakness h. Joint pain i. Disorientation j. Fatality Vitamin E A. General 1. Link between vegetable oil and normal reproduction in rats was first noted in 1922 2. Vitamin E is a family of 8 compounds a. Alpha-tocopherol: most active form b. Beta- tocopherol c. Gamma- tocopherol: found in many vegetable oils, may have health benefits, but not as active as alpha-tocopherol d. Delta- tocopherol e. Alpha-tocotrienol f. Beta- tocotrienol g. Gamma- tocotrienol h. Delta- tocotrienol 3. Chemistry a. Long carbon tail that can exist in many isomeric forms b. Ringed structure B. Vitamin E in Foods 1. Plant oils (e.g., cottonseed, canola, safflower, sunflower) 2. Wheat germ 3. Asparagus 4. Peanuts 5. Sunflower seeds 6. Products made from plant oils (e.g., margarine, shortening, salad dressing) 7. Vitamin E content of foods may vary due to harvesting, processing, storage, and cooking (susceptible to destruction by oxygen, metals, light, and high temperatures) C. Vitamin E Needs 1. RDA (adult men and women): 15 mg, based on amount needed to prevent hemolysis (breakdown of RBC membranes) 2. DV: 30 IU 3. 4. D. E. F. G. H. Typical intakes are 2/3 RDA Converting IU to mg a. For a synthetic source (e.g., supplements): 1 IU = 0.45 mg b. For a natural source (most potent), 1 IU = 0.67 mg Absorption of Vitamin E 1. Efficiency ranges from 20 - 70% depending on amount consumed and absorption of dietary fat 2. Incorporated into micelles with dietary fat in the small intestine; requires bile and pancreatic enzymes 3. Absorbed by small intestinal cells 4. Incorporated into chylomicrons Transport of Vitamin E 1. Transported as part of chylomicrons in lymph, then bloodstream 2. Triglycerides and some vitamin E are removed from chylomicrons by body cells, chylomicron remnant remains 3. Chylomicron remnant (containing vitamin E) is transported to liver 4. Vitamin E is repackaged as VLDL, LDL, and HDL for delivery to body tissues 5. No specific transport protein Storage of Vitamin E 1. Does not accumulate in liver 2. Mostly stored in adipose tissue Excretion of Vitamin E 1. Bile (mostly) 2. Urine 3. Skin Functions of Vitamin E 1. Antioxidant a. Free radical: unstable compound with unpaired electron that acts as a strong oxidizing agent; destructive to cell components (e.g., cell membranes and DNA) b. In lipid-rich areas of the body, free radicals initiate lipid peroxidation reactions that create lipid peroxyl radicals c. Vitamin E donates a hydrogen to lipid radicals to stop the oxidation reaction, thus reducing oxidative stress d. Reduction in oxidative stress may lower risk for CVD, certain cancers, cognitive decline, and impaired immune function e. Free radicals have some beneficial roles (e.g., immune function) f. Other antioxidant systems in the body i. Glutathione peroxidase: catalyzes breakdown of hydrogen peroxides and lipid peroxides; requires selenium ii. Catalase: neutralizes free radicals in peroxisomes iii. Superoxide dismutase: eliminate superoxide radicals; requires copper, zinc, and/or manganese I. J. 12.5 iv. Carotenoids v. Vitamin C vi. Bilirubin vii. Uric acid viii. Ubiquinone ix. Lipoic acid x. Metal-binding proteins 2. Interactions with other nutrients a. Due to the activity of selenium in the glutathione peroxidase pathway, adequate selenium intake reduces vitamin E needs b. Vitamin C may aid in partial regeneration of vitamin E after vitamin E donates a hydrogen to a free radical Vitamin E Deficiency 1. High-risk populations a. Fat malabsorption b. Smokers: smoking increases oxidative stress c. Preterm infants: born with limited stores of vitamin E, insufficient intestinal absorption of vitamin E 2. Consequences a. Hemolytic anemia: RBCs break down faster than they can be replaced b. Impaired immune function c. Neurological changes Vitamin E Toxicity 1. Consequences a. Hemorrhaging: insufficient clotting leads to excessive bleeding b. High intake of alpha-tocopherol may decrease gamma-tocopherol activity; mixed isomer supplement preparations may be preferable 2. High-risk populations a. Concurrent use of anticoagulant medications 3. UL: 1000 mg (1500 IU) of alpha-tocopherol from natural sources or 1100 IU from synthetic sources Vitamin K A. General 1. Vitamin K is a family of compounds known as quinones a. Phylloquinones (K1): from plant sources b. Menaquinones (K2): from fish oils and meats; synthesized by intestinal bacteria c. Menadione: synthetic compound that can be converted to menaquinone in body tissues 2. Stable to heat processing 3. Susceptible to destruction by light B. Vitamin K Sources 1. 2. C. D. E. F. G. H. 10% from bacterial synthesis in colon 90% from dietary sources a. Green leafy vegetables (e.g., kale, turnip greens, parsley, salad greens, cabbage, spinach) b. Broccoli c. Peas d. Green beans e. Vegetable oils (e.g., soy, canola) Vitamin K Needs 1. AI, based on providing adequate vitamin K for blood clotting a. Adult women: 90 µg b. Adult men: 120 µg 2. DV: 80 µg Absorption of Vitamin K 1. 80% absorption efficiency 2. Taken up by small intestine (requires bile and pancreatic enzymes), incorporated into chylomicrons 3. 10% of needs are provided by colonic bacteria Transport of Vitamin K 1. Incorporated into VLDL and LDL Storage of Vitamin K 1. Liver 2. Bone Excretion of Vitamin K 1. Bile 2. Urine (minor) Functions of Vitamin K 1. Blood clotting (see Figure 12-20) a. Synthesis of clotting factors by the liver b. Conversion of preprothrombin to prothrombin (active blood-clotting factor) i. CO2 added to glutamic acid to yield Gla protein (gammacarboxyglutamic acid) ii. Conversion also relies on calcium binding: Gla residues bind calcium to form blood clots c. Anticoagulant medications (e.g., warfarin) inhibit reactivation of prothrombin d. Consistent vitamin K intake and avoidance of vitamin K supplements are necessary for individuals on anticoagulant therapies 2. Bone metabolism: some vitamin K-dependent Gla proteins are synthesized in bone a. Osteocalcium b. Matrix Gla protein I. J. 12.6 c. Protein S 3. Reduction of inflammation Vitamin K Deficiency 1. High-risk populations a. Prolonged antibiotic therapy b. Fat malabsorption c. Newborns: vitamin K stores are low at birth; vitamin K injections are administered d. Megadoses of other fat-soluble vitamins i. Vitamin A inhibits intestinal absorption ii. Vitamin E decreases vitamin K-dependent clotting factors 2. Consequences a. Hemorrhage Vitamin K Toxicity 1. No UL has been set 2. Stored in liver and bone, but more readily excreted than other fat-soluble vitamins 3. High doses of menadione may result in hemolytic anemia, excess bilirubin in the blood, and death Dietary Supplements: Healthful or Harmful? A. 40% of US adults regularly use vitamin/mineral supplements B. Reasons for use 1. Reduced susceptibility to disease 2. Compensate for dietary insufficiencies 3. Protect against age-related changes 4. Enhance well-being C. Dietary Supplement Health and Education Act (DSHEA): supplement is any product intended to supplement the diet that contains one or more vitamins, minerals, amino acids, herbs, botanicals, or plant extracts 1. FDA does not have the authority or resources to closely monitor dietary supplements unless they are dangerous or marketed using illegal claims 2. Supplement manufacturers may not claim that supplements will prevent, treat, or cure diseases 3. Structure/function claims are allowed 4. Claims that are not related to diseases are allowed 5. Evidence is not always available to support claims 6. Quality, purity, and consistency are not closely monitored by FDA, but voluntary labeling with US Pharmacopeia symbol indicates that product meets established industry standards for strength, quality, purity, packaging, labeling, solubility, and storage life D. Dietary supplements are no substitute for a healthy diet 1. Lack of fiber 2. 3. 4. E. F. 12.7 Lack of phytochemicals Limited calcium content Risk of toxicities and nutrient interactions a. Excessive zinc interferes with iron and copper absorption b. High folate masks vitamin B-12 deficiency c. Excessive vitamins A or D may result in toxicity symptoms Some situations necessitate use of multivitamin/mineral supplements 1. Iron supplements for women with excessive menstrual losses 2. Iron and folate supplements for pregnant or breastfeeding women 3. MVI for those with limited calorie intakes 4. Calcium, iron, zinc, and vitamin B-12 for vegans 5. Vitamin K for newborns 6. Fluoride for infants and young children 7. Vitamin D for those with limited sun exposure and low intake of fortified dairy products 8. Calcium and vitamin D for those with low dairy intake due to lactose intolerance or milk allergies 9. Specific vitamins or minerals for those with medical conditions that alter nutrient metabolism Guidelines for choosing MVI 1. Nationally-recognized brand 2. No more than 100% DV for nutrients listed 3. Avoid exceeding UL for any nutrient from combination of supplements, foods, and fortified foods 4. Avoid superfluous ingredients (e.g., bee pollen, lecithin, hesperidin complex, inositol, laetrile, pangamic acid, PABA) Global Perspective: Vitamin A Deficiency A. 100 - 140 million children worldwide suffer from vitamin A deficiency B. At-risk populations 1. Children a. Leading cause of preventable blindness in children: 250,000 - 500,000 cases/year b. Increased death from infections 2. Women of childbearing age a. Increased risk of HIV transmission from mother to fetus b. Maternal mortality C. Vitamin A Global Initiative: partnership among World Health Organization, United Nations Children’s Fund, Canadian International Development Agency, US Agency for International Development, and Micronutrient Initiative formed in 1998 to combat vitamin A deficiency 1. Promotes breastfeeding 2. Promotes fortification of foods 3. 4. 5. 12.8 Provides educational programs to increase home gardening of vitamin A-rich foods Provides vitamin A supplements to at-risk populations - shown to decrease vitamin A-related mortality by 15% in affected areas Development of programs to increase production and access to nutrient-rich foods Expert Perspective: Vitamin D: “The Iceberg below the Surface” A. Vitamin D deficiency is reemerging as a global health concern for children and adults due to low dietary intakes and limited UV light exposure B. Prevention of vitamin D-related bone disorders and maintenance of calcium homeostasis are only the “tip of the iceberg” with regard to the role of vitamin D in the body C. Important roles in gene control and cell cycle regulation 1. Diabetes 2. Colon, prostate, and breast cancer 3. CVD 4. Autoimmune diseases (e.g., multiple sclerosis) D. Some scientists advocate higher vitamin D intake recommendations: 75 - 100 µg, compared to current recommendations of 5 - 15 µg E. UL is currently set at 50 µg (2000 IU)